The nasal vaccine has received approval from the Indian government. It will be made first available in private hospitals and utilised as a heterologous booster. Beginning today, it will be a part of the Covid vaccine programme.
Who can take the nasal vaccine?
The intranasal vaccine will be India’s first such booster dosage because it is unnecessary. It can be given to anyone who is older than 18 years old.
The vaccination, which is administered through the nose without the use of a needle, will be accessible at private clinics all around the nation in a few days. On the government’s CoWIN vaccine management platform, it is anticipated to be an option starting late Friday.
How Do Nasal Vaccines Work?
Since the virus typically enters the body through the nose, the nasal vaccine triggers your immune system to produce proteins in your blood and in your nose to aid in fighting the infection. Your nostrils will be sprayed with the vaccine by a doctor using a tiny, needle-free syringe. It will take the spray two weeks to begin acting on the body.
The nasal vaccination targets immune cells that are found in the mucosa membrane and tissue, resulting in systemic immunity as well as mucosal immunity at various sites, including the lungs and intestines. Therefore, a nasal vaccine may be better able to protect large groups of people from the lethal infection and stop the onset of even minor symptoms.
The nasal vaccine not only protects against Covid, but also prevents the disease from spreading by encouraging a particular sort of immunity that is mostly present in the cells that line the nose and throat.
